Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

Data ReadoutpositivePositive

AI Analysis

Summary

Cingulate announced publication of Phase 3 ADHD trial results in the Journal of Child and Adolescent Psychopharmacology. The publication represents positive clinical trial outcomes for the company's ADHD treatment program.

Clinical Trial Data

Phase

Phase 3

Outcome Details

Phase 3 ADHD trial results published in Journal of Child and Adolescent Psychopharmacology

Importance:6/10

Sentiment:

0.60

Phase 3ADHDPublicationClinical Trial

Related Companies

$CING

Read the original article

Published by yahoo_finance on July 30, 2026 12:30 PM

Read Original